Navigation Links
AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
Date:8/12/2008

the Dresden Technical University. In 1995, he received the Galenus-von-Pergamon prize for having developed alkylphospholipids as a new class of anti-tumor agents. Prof. Engel is the author of more than 250 scientific articles, several books and he applied for more than 100 patent applications.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization.

News releases and additional information are available at http://www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments except if we
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris to Announce Second Quarter 2008 Financial and Operating Results on August 12, 2008
2. AEterna Zentaris Sells Quebec City Building for $7.1 million
3. AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting
4. AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal
5. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
6. AEterna Zentaris to Announce First Quarter 2008 Financial and Operating Results and Hold Annual Shareholder Meeting on May 7, 2008
7. AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan
8. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
9. AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia
10. AEterna Zentaris Announces Changes to its Management Team
11. AEterna Zentaris and Paladin Labs Complete Sale and Purchase of Miltefosine Rights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... , Nov. 18, 2014  Novira Therapeutics, Inc., ... curative treatment of chronic hepatitis B virus (HBV) infection, ... was appointed to its Scientific Advisory Board (SAB).  ... our SAB," said Christian S. Schade , Chief ... clinical development experience which will be invaluable to Novira ...
(Date:11/15/2014)... November 13, 2014 Collaborative Consulting, a ... were named one of the Boston Globe’s “Top Places ... Sized Businesses in Massachusetts to receive the honor. , ... who take care of their most valuable resource: the ... presented annually, and are based on an array of ...
(Date:11/15/2014)... Phoenix, AZ (PRWEB) November 14, 2014 ... the DNA analysis market has already proven itself as ... consumer usage. DNA Spectrum recognizes this opportunity with its ... provides customers with a comprehensive genealogical history for a ... myDNA Safe storage service and forthcoming ...
(Date:11/15/2014)... LONDON , Nov. 14, 2014 Algenol Biofuels ... 6th at the Oceanographic Museum of Monaco ... CleanEquity Monaco is an annual invitation-only event hosted by ... investment bank. Other partners and sponsors include ... Foundation, Covington & Burling, Cranfield University, PR Newswire, the Monte-Carlo ...
Breaking Biology Technology:Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3Collaborative Consulting Honored with Boston Globe Top Places to Work 2014 2DNA Spectrum Begins the Search For a New Chief Executive Officer 2DNA Spectrum Begins the Search For a New Chief Executive Officer 3Algenol Biofuels Selected to Present at CleanEquity Monaco 2015 2
... HGS reacquires GSK rights to TRAIL receptor antibodies in return for ... reduction in Syncria(R) royalties - ... development program expands -, ROCKVILLE, Md., April 16 Human Genome,Sciences, ... the TRAIL receptor antibodies HGS-ETR1 (mapatumumab) and HGS-ETR2,(lexatumumab) from GlaxoSmithKline (GSK), in ...
... April 16 Masimo (Nasdaq:,MASI), the inventor ... announced an,agreement with Atom Medical Corporation, a ... to integrate Masimo Rainbow SET Pulse,CO-Oximetry into ... "Since standardizing on Masimo technology more than ...
... On Wednesday, April,23, 2008, GlaxoSmithKline plc will announce ... ended March 31, 2008. The announcement is,scheduled to ... approximately 7:00,am (ET) US and will be available ... Following the announcement, JP Garnier, Chief Executive Officer ...
Cached Biology Technology:Human Genome Sciences Advances Oncology Portfolio 2Human Genome Sciences Advances Oncology Portfolio 3Human Genome Sciences Advances Oncology Portfolio 4Human Genome Sciences Advances Oncology Portfolio 5Human Genome Sciences Advances Oncology Portfolio 6Atom Medical Adopts Masimo Rainbow SET Technology 2Atom Medical Adopts Masimo Rainbow SET Technology 3Atom Medical Adopts Masimo Rainbow SET Technology 4
(Date:11/4/2014)... research study examining only marketing directed at children ... restaurants has found that the majority of black, ... such marketing tactics. , Authored by Arizona State ... study is the first to examine the use ... of fast food restaurants and its relationship to ...
(Date:11/4/2014)... A majority of Madagascar,s 101 species of lemurs are ... for the rainforests they call home. A new study ... can have on rainforest tree populations, which raises concerns ... the region,s rich biodiversity. , A large proportion of ... Lemurs in turn disperse the seeds of their ...
(Date:11/3/2014)... , Nov. 3, 2014 Research and ... "Cell Therapy - Technologies, Markets and Companies" to ... cell therapy technologies and methods, which have already started to ... stem cell transplantation is replacing the old fashioned bone marrow ... Cell therapy is bound to become a part of medical ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3
... and breadth of coverage, applicability and usefulness of the ... (GBIF) has set a goal of making one billion ... portal by December 2008., GBIF calls on holders of ... sharing their data to deepen and broaden biodiversity data ...
... another layer of competition to the mating game, scientists ... of female mammals can sense the presence of sperm ... This may be the molecular mechanism behind post-copulatory sexual ... partners play a role in determining which sperm fertilizes ...
... conservationists in Manchester are turning to physics to investigate ... American tree frogs. In a unique collaborative project, ... University of Manchester have joined forces with The Manchester ... frogs. Physicist Dr Mark Dickinson, working with Andrew ...
Cached Biology News:GBIF sets goal of mobilizing 1 billion records by end of 2008 2New evidence for female control in reproduction 2New evidence for female control in reproduction 3Sunbathing tree frogs' future under a cloud 2
Human Cystatin A MAb (Clone 224705)...
...
Microlite 2+ Plate, round bottom; an irradiated, high binding surface with enhanced dynamic range, extra high reflectivity and minimal cross talk for low signal luminescent reactions....
... temperature freezers offer a superior sample ... biological samples with high capacities. Innovative ... doors ensure excellent warming protection and ... oriented accessories simplify tracking of sample ...
Biology Products: